Crossmark

Neutralization of hepatitis B virus with vaccine-escape mutations by hepatitis B vaccine with large-HBs antigen

Crossref DOI link: https://doi.org/10.1038/s41467-022-32910-z

Published Online: 2022-09-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Washizaki, Ayaka

Murayama, Asako

Murata, Megumi

Kiyohara, Tomoko

Yato, Keigo

Yamada, Norie

Aly, Hussein Hassan

Tanaka, Tomohisa

Moriishi, Kohji https://orcid.org/0000-0002-9542-5188
Nishitsuji, Hironori

Shimotohno, Kunitada

Goh, Yasumasa

Ishii, Ken J. https://orcid.org/0000-0002-6728-3872
Yotsuyanagi, Hiroshi

Muramatsu, Masamichi

Ishii, Koji

Takahashi, Yoshimasa https://orcid.org/0000-0001-6342-4087
Suzuki, Ryosuke

Akari, Hirofumi https://orcid.org/0000-0003-2166-6015
Kato, Takanobu https://orcid.org/0000-0003-1620-1360
Funding

Funding for this research was provided by:

Japan Agency for Medical Research and Development (JP19fk0310120)

Japan Agency for Medical Research and Development (JP19fk0310120)

Japan Agency for Medical Research and Development (JP19fk0310120)

Japan Agency for Medical Research and Development (JP19fk0310120)

Japan Agency for Medical Research and Development (JP22fk0310503)

Japan Agency for Medical Research and Development (JP19fk0310120)

Japan Agency for Medical Research and Development (JP21fk0310103)

Japan Agency for Medical Research and Development (JP22fk0310503)

Japan Agency for Medical Research and Development (JP22fk0310517)
License Information

Text and Data Mining valid from 2022-09-05

Version of Record valid from 2022-09-05
More Information

Article History

Received: 20 March 2022

Accepted: 22 August 2022

First Online: 5 September 2022

Competing interests

: Y.G. is an employee of Beacle, Inc. The other authors declare no competing interests.

Document is current

Any future updates will be listed below